Form 4: Catheter Precision Director Granted 50,000 Stock Options

Catheter Precision, Inc. Director Martin J. Colombatto was granted 50,000 stock options with an exercise price of $0.18, vesting over three years.

Summary

• Martin J. Colombatto, a Director of Catheter Precision, Inc. (VTAK), acquired 50,000 options to purchase common stock.
• The options have an exercise price of $0.18 per share.
• The grant date for these options was August 12, 2025.
• The options will vest at a rate of one-third per year, beginning on the first anniversary of the grant date.
• The expiration date for these options is August 12, 2035.

Sentiment

Score: 6

Explanation: The grant of stock options to a director is generally viewed as a neutral to slightly positive event, as it aligns the director's financial interests with long-term shareholder value. It is a standard compensation practice.

Positives

• The grant of stock options to a director aligns management's interests with those of shareholders, incentivizing long-term company performance.

Future Outlook

The filing details a stock option grant with a vesting schedule, indicating future exercisability contingent on continued service and company performance.

Industry Context

This is a routine insider compensation event, common across various industries, aimed at retaining and incentivizing key personnel. It does not provide broader industry trends or competitive insights.

Related Party Transactions

• The grant of 50,000 stock options to Martin J. Colombatto, a Director, constitutes a transaction with a related party as part of his compensation package.

Stakeholder Impact

• Shareholders: The option grant aims to align the director's long-term interests with shareholder value creation.
• Management/Director: Provides an incentive for the director to contribute to the company's growth and stock price appreciation.

Next Steps

• The options will begin vesting one-third per year starting on the first anniversary of the August 12, 2025 grant date.

Key Dates

Keywords

Catheter Precision, VTAK, Stock Options, Insider Transaction, Director Compensation, Form 4